21 Manufacture of basic pharmaceutical products and pharmaceutical preparations

Enterprise Europe Network (Profile:BRPL20210827001)

Type: 
Cooperation
Short description of advertisement: 
An established North East UK company who sell sneaker based care and display products to both business to consumer and business to business clients, is looking for manufacturers to help produce their existing product and add extra products to their range.

This Polish company was founded this year in order to create an entity for new business activity. The owner of the company has many years of experience in manufacturing natural cosmetics and candles. The new products to be introduced to the Polish market are dietary supplements.
The company would like to establish contacts with producers or suppliers of ubiquinone - Coenzyme Q10, D-chiro-inositol, pyridoxal 5-phosphate, Acetyl L-carnitine, d-chiro inositol for supplier agreement.
For the beginning a company would like to order:
- 10 kg of ubiquinone - Coenzyme Q10,
- 75 kg of D-chiro-inositol,
- 5 kg of pyridoxal 5-phosphate,
- 75 kg of Acetyl L-carnitine,
- 30 kg of d-chiro inositol. 
A company is looking for new suppliers of raw materials under supplier agreement.

 

For more information please contact Enterprise Europe Network Latvia.

Contact person: 
Enterprise Europe Network Latvia
Contact languages: 
English
Country: 
Poland
Address: 
Perses Street 2, Riga, LV-1442, Latvia
Phone: 
+371-67039430
Fax: 
+371-67039431
E-mail: 
info [at] een.lv
Proposal valid till: 
Saturday, 3 September, 2022

Enterprise Europe Network (Profile:BRSE20210511001)

Type: 
Cooperation
Short description of advertisement: 
Sweden's largest independent wholesaler supplies health food stores with products that are better for both people and planet. Currently the company is looking to expand its offer and seeks new EU manufacturers of gummy supplements.

The Swedish company is Sweden's largest indepentent wholesaler for health food stores. The company was founded in 1993 and has 35 employees. With a 5000 m2 warehouse, the company distributes products for health food stores and some of Swedens biggest e-commerce stores in the same category. The company strives to offer products that are friendly towards nature and people. 

In order to meet the needs of the market, the company is now looking for a manufacturer that can provide gummy supplements through private label. The company is interested in a manufacturing agremeent with a supplier that can produce gummy supplements under the brand of the Swedish company. 

The manufacturer should be based in the EU and able to deliver a minimum order quantity between 1000-3000 pcs of each stock keeping unit. The product range should cover gummy supplement for skin, tan, hair, probiotics, as well as multivitamins. Flavors and colors are of less importance. The Swedish company however emphasizes the importance that the gummies do not contain any harmful substances.

 

For more information please contact Enterprise Europe Network Latvia.

Contact person: 
Enterprise Europe Network Latvia
Contact languages: 
English
Country: 
Sweden
Address: 
Perses Street 2, Riga, LV-1442, Latvia
Phone: 
+371-67039430
Fax: 
+371-67039431
E-mail: 
info [at] een.lv
Proposal valid till: 
Thursday, 18 August, 2022

LIEPAJAS SPECIALAS EKONOMISKAS ZONAS SIA "NORDEPLAST" Liepāja special economic zone LTD

General Information
Registration number: 
42103074684
Year of foundation: 
2016
Industry (NACE 2): 
MANUFACTURING
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2 Manufacture of pharmaceutical preparations
21.20 Manufacture of pharmaceutical preparations
Number of employees: 
11 - 20
Turnover (EUR):
400 001 - 500 000
2020
Export volume (EUR):
100 001 - 500 000
2020
Export countries: 
Armenia
Canada
Georgia
Kyrgyzstan
Lithuania
Mongolia
Poland
Russia
Ukraine
Certificates: 
ISO 9001:2015, ISO 13485:2016
Achievements: 
Company NordePlast was founded in year of 2016 with the aim of producing modern medical products. The factory is certified according to ISO 13485 and ISO 9001 systems and is equipped with high performance multifunctional equipment. In the production process, advanced technologies are used and material from the best manufacturers in the world is selected. The products are successfully exported to various countries of the world.
Head of the Company
Name, surname: 
Romans Gramiko
Position: 
Member of the board
Contact Information
Address: 
Ziemelu street 19, Liepaja, LV-3405, Latvia
Phone: 
+371-20037773
E-mail: 
info [at] nordeplast.com
Contact persons' name, surname: 
Anna Tacenko
Contact persons' position: 
Sales manager
Languages spoken : 
English
Latvian
Russian
Business Profile and Cooperation Interests
Images: 

PHARMIDEA

General Information
Registration number: 
4000379117
Year of foundation: 
2005
Industry (NACE 2): 
MANUFACTURING
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.1 Manufacture of basic pharmaceutical products
21.10 Manufacture of basic pharmaceutical products
Number of employees: 
51 - 100
Turnover (EUR):
5 000 001 - 10 000 000
2019
5 000 001 - 10 000 000
2018
Export volume (EUR):
5 000 001 - 10 000 000
2019
5 000 001 - 10 000 000
2018
Export countries: 
Colombia
Croatia
Czech Republic
Ecuador
Estonia
Finland
France
Germany
Ireland
Israel
Kazakhstan
Libya
Malaysia
Mexico
Morocco
Philippines
Portugal
Russia
Saudi Arabia
Spain
Sweden
Switzerland
Taiwan
Thailand
Ukraine
United Arab Emirates
United Kingdom
Vietnam
Certificates: 
EU GMP
Achievements: 
EU GMP, SFDA, JFDA, UAE, Canada, Philippines, Russia, Ukraine, Turkey, Korea, Israel, Vietnam, Taiwan GMP approvals
Head of the Company
Name, surname: 
Mr Iskandar Ismagilov
Position: 
Chairman of the Board
Contact Information
Address: 
Rupnicu Street 4, Olaine, LV2114, Latvia
Phone: 
+371-67069889
E-mail: 
ilze.prikule [at] pharmidea.lv
Contact persons' name, surname: 
Ilze Prikule
Contact persons' position: 
Busines Development and Sales manager
Languages spoken : 
English
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

Out-licensing, manufacturing, co-development and co-manufacturing, CTD, technology transfer, services related to finished dosage forms packaging, serialization

Target export countries: 
Australia
Canada
New Zealand
Singapore
Cooperation interests: 

Out-licensing of own sterile drugs, development and manufacturing of sterile niche injectables, technology transfer

Enterprise Europe Network (Profile:BRUK20210311001)

Type: 
Cooperation
Short description of advertisement: 
UK company offers a manufacturing agreement to a European manufacturer to produce anti chafe balm prevention products.

Established in 2017, this UK company has developed a range of products designed for people seeking to protect and maintain their skin.
The balm product is currently manufactured in China and an alternative manufacturer is sought in Europe.
The balm product is sold in UK, Ireland, USA, Australia, New Zealand and Canada as well as some European countries.
Sourcing a manufacturing facility closer to UK will give the company greater control of their product and future developments, reduce lead times in orders and the carbon footprint.
The balm will protect skin against rubbing that causes chafing and irritation of the skin by maintaining moisture and repelling water. It creates a barrier between the skin and conditions that cause excess moisture in the skin.
The balm is for anyone who is active, from running a marathon to simply going for a walk, cycle or swim and any other activity.
It is available in 3 sizes 13g, 25g and 45g and includes 2 types unisex and female versions.
The product is made with natural ingredients, no petroleum, animal or synthetic products are used in the balm and it is paraben & phthalate free. The balm is always dry, never greasy. It feels light on the skin and goes on dry and is invisible for all day protection.
Ingredients include hydrogenated vegetable oil, octyldodecanol, beewax, sweet almond, coconut oil, vitamin E and vanilla fragrance.
The balm is supplied in the form of an ointment as this provides an effective means of delivering the active ingredient directly to the required area.
The manufacturing process breaks down into four individual operations: preparation of the oil phase where ingredients are dispersed into the oil. The elements that are the emulsifiers, thickeners and stabilisers are then dispersed into water in a separate vessel. The two phases are then blended under vigorous agitation to form the emulsion. The active Ingredient is finally efficiently dispersed to maximise yield and product effectiveness. .Consistent product uniformity, quality and repeatability is required from the process.
Current manufacturing volumes have grown year on year to approximately 40,0000 pieces in 2019.
The main route to market is online sales, one distributor is currently active, with further distributors to be appointed.
This company offers a manufacturing agreement to the right company, and a long term relationship is envisaged with the successful partner.

 

For more information please contact Enterprise Europe Network Latvia.

Contact person: 
Enterprise Europe Network Latvia
Contact languages: 
English
Country: 
United Kingdom
Address: 
Perses Street 2, Riga, LV-1442, Latvia
Phone: 
+371-67039430
Fax: 
+371-67039431
E-mail: 
info [at] een.lv
Proposal valid till: 
Thursday, 2 June, 2022

Enterprise Europe Network (Profile:BRXK20210527002)

Type: 
Cooperation
Short description of advertisement: 
A Kosovar distributor with 8 years market experience is looking for additional products to add to its ‎portfolio under distribution services agreements. The distributor’s current focus is on pharmaceutical products, pre-pharmaceutical products, medical devices, covid tests,etc.

The Kosovar company was established in 2013. It is a commercial agency specialized in selling of pharmaceutical products (over the counter and para pharmaceutical products) and medical devices to pharmacies and hospitals. The company has a large commercial network in Kosovo.

The company wants to expand its current product portfolio and extend its list of suppliers and identify new partners with a comparative advantage in terms of innovative products, quality or price.

The company is looking for producers of pharmaceutical products and of medical devices for cooperation under distribution agreement.The products must be compliant with EU Health regulation ( Directive 2001/83/EC).

 

For more information please contact Enterprise Europe Network Latvia.

Contact person: 
Enterprise Europe Network Latvia
Contact languages: 
English
Country: 
Kosovo
Address: 
Perses Street 2, Riga, LV-1442, Latvia
Phone: 
+371-67039430
Fax: 
+371-67039431
E-mail: 
info [at] een.lv
Proposal valid till: 
Thursday, 2 June, 2022

Enterprise Europe Network (Profile:BRRS20210105001)

Type: 
Cooperation
Short description of advertisement: 
The Serbian distributor of pharmaceutical, medical, and cosmetic products and medical devices looks for suppliers willing to enter the Serbian market. The products can be both registered and unregistered.

The Serbian company has more than 26 years of experience in wholesale and logistic support for the pharmaceutical industry.  Based in Belgrade it has grown into one of the leading companies in the field of import and registering pharmaceutical and medical products. The company also imports and acquires all necessary certificates for medical devices. They deliver partners' products registered and unregistered according to Serbian laws to the extensive network of hospitals (also for clinical trials), pharmacies, vaccination stations, and patients' houses. The company cooperates with both multinationals and small manufacturers. They have experience in collaboration with partners from the EU countries as well as from European countries outside the EU (Russia, Ukraine, Moldavia, Byelarus, Bosnia-Herzegovina, and Montenegro).

The company has the necessary certificates for the import and distribution of pharmaceuticals in Serbia. They fulfil the requirements of the GDP (Good distribution practise) for the pharmaceutical industry, which is especially important in the case of products requiring controlled temperature conditions, such as in the so-called 'cold chain'. It conducts business in line with the ISO 9001:2015 standards. The company is part of the continuous quality monitoring system by the Ministry of the health of the Republic of Serbia and the certification body.

The company offers comprehensive distribution services. They are looking for manufacturers and suppliers of pharmaceutical, medical and cosmetic products to sell these products on the Serbian market. The company offers also services complementing the distribution process, such as warehousing in their own facility, transport and logistics in the whole country, and support in finding marketing partners. Their services include also dealing with pharmaceutical products imported from outside the EU and awaiting clearance, import of products, medical devices, supplements and cosmetics for a clinical trial.

 

For more information please contact Enterprise Europe Network Latvia.

Contact person: 
Enterprise Europe Network Latvia
Contact languages: 
English
French
Country: 
Serbia
Address: 
Perses Street 2, Riga, LV-1442, Latvia
Phone: 
+371-67039430
Fax: 
+371-67039431
E-mail: 
info [at] een.lv
Proposal valid till: 
Sunday, 20 March, 2022

Enterprise Europe Network (Profile:BRGR20210310001)

Type: 
Cooperation
Short description of advertisement: 
The Greek SME company represents and manages a portfolio of specialised clinical nutrition products and medical equipment that can be delivered at home patients. It is a leading company in the sector and is licensed by the Hellenic Medicines Agency.

The Greek SME company is active in the representation and sale of specialised clinical nutrition preparations and medical equipment used for patients whose care is being managed at home. The company opened its doors back in 2015 and is licensed by the Hellenic Medicines Agency (EOF).

Currently, the company has selected and distributes in the Greek market a variety of products of leading companies in the categories of clinical nutrition products, medical dressings (bandages, adhesive tapes excluding gauze bandage and gauze pads), parenteral antibiotics antifungal and injectable solutions etc. 

The dietary department of the company in collaboration with the treating physicians offers nutritional support and specialized advice to patients.

The market size of enteral nutrition sector in Greece keeps growing year on year and so the company seeks to establish new business leads through trade intermediary cooperation agreements in order to remain in a position as a key supplier of such products within the domestic market.

Conversely, the company is interested in promoting in the domestic market enteral nutrition products that belong to the foods for special medical purposes (FSMP) category. The special medical purposes products are specialized foods designed to help meet the nutritional or dietary needs of patients living with a disease, disorder or medical condition who are temporarily or permanently unable to achieve an adequate nutritional intake from normal foods or through modification of the normal diet.

The company is specifically looking for manufacturers of ready-made enteral nutrition products that can be provided by means of the gastrointestinal tract (tube feeding) or liquid & oral form (taken predominantly via the mouth).

It is the company's intention to enter into trade intermediary agreements with the manufacturers. The considered type of agreement is commercial agency agreement with exclusive rights for the Greek market.

 

For more information please contact Enterprise Europe Network Latvia.

Contact person: 
Enterprise Europe Network Latvia
Contact languages: 
English
Country: 
Greece
Address: 
Perses Street 2, Riga, LV-1442, Latvia
Phone: 
+371-67039430
Fax: 
+371-67039431
E-mail: 
info [at] een.lv
Proposal valid till: 
Monday, 14 March, 2022

Enterprise Europe Network (Profile:BRFR20201124001)

Type: 
Cooperation
Short description of advertisement: 
A France based sales agent specialized in food & beverages packaging since 2013. The company is willing to develop its current portfolio by adding complementary product ranges.

An independent French sales agent established its business seven years ago. He mainly serves food & beverages packaging sector. He is connected to a large base of industrial and distribution partners in whole France. Today he is willing to expand his activity as Commercial Agent still in an international environment with food producers or raw materials for food production companies. 

He considers both producers of conventional and organic food or raw materials from Belgium, Greece, Italy and Spain. Potential partners should will to increase sales outside their home market and have a real consideration for the French market. 

The sales agent is looking for a commercial agency agreement based on a commission related to the invoicing value but could be also based on other parameters. 

 

For more information please contact Enterprise Europe Network Latvia.

Contact person: 
Enterprise Europe Network Latvia
Contact languages: 
English
French
Country: 
France
Address: 
Perses Street 2, Riga, LV-1442, Latvia
Phone: 
+371-67039430
Fax: 
+371-67039431
E-mail: 
info [at] een.lv
Proposal valid till: 
Sunday, 6 February, 2022

Enterprise Europe Network (Profile:BRCN20201103001)

Type: 
Cooperation
Short description of advertisement: 
This Chinese pharmaceutical company has cooperation with many domestic pharmaceutical companies and industry funds. It has a mature platform for the R&D and production of macromolecule and small-molecule drugs.

The Chinese company is a pharmaceutical company with a number of mature drug production channels. The products cover a wide range of diseases, such as tumors, cardiovascular and cerebrovascular diseases, cardio-cerebrovascular disease, and nervous system diseases. A number of drugs are currently on various stages of clinical trials. The Chinese company plans to bring in some of the new drug projects, specifically endocrine, cardio-cerebrovascular, ocular and autoimmune diseases and tumor related drugs from the European Union via a patent license agreement or patent transfer.
With patent licensing partnership, the European company transfers the rights of R&D and sales of the selected drugs in China to the Chinese company, and the Chinese company is obliged to pay the license fee of the project in a lump sum to the European side, or pay by milestone according to different stages of the project as specified in the agreement.
The target European company should have a mature drug development team. The target innovative drug program should be Investigational New Drugs (IND) to treat endocrine, cardio-cerebrovascular, ocular and autoimmune related diseases and tumors approved in Europe by the European Medicines Agency (EMA) or in the United States by the Food and Drug Administration (FDA ), with pharmacodynamics, pharmacokinetics, and safety evaluation.

 

For more information please contact Enterprise Europe Network Latvia.

Contact person: 
Enterprise Europe Network Latvia
Contact languages: 
Chinese
English
Country: 
China
Address: 
Perses Street 2, Riga, LV-1442, Latvia
Phone: 
+371-67039430
Fax: 
+371-67039431
E-mail: 
info [at] een.lv
Proposal valid till: 
Monday, 15 November, 2021

Pages

Subscribe to 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations